Correlation Between Recursion Pharmaceuticals and Invivyd
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Invivyd at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Invivyd into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and Invivyd, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Invivyd and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Invivyd. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Invivyd.
Diversification Opportunities for Recursion Pharmaceuticals and Invivyd
-0.16 | Correlation Coefficient |
Good diversification
The 3 months correlation between Recursion and Invivyd is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Invivyd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invivyd and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Invivyd. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invivyd has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Invivyd go up and down completely randomly.
Pair Corralation between Recursion Pharmaceuticals and Invivyd
Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 0.65 times more return on investment than Invivyd. However, Recursion Pharmaceuticals is 1.54 times less risky than Invivyd. It trades about -0.06 of its potential returns per unit of risk. Invivyd is currently generating about -0.22 per unit of risk. If you would invest 780.00 in Recursion Pharmaceuticals on November 4, 2024 and sell it today you would lose (56.00) from holding Recursion Pharmaceuticals or give up 7.18% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Recursion Pharmaceuticals vs. Invivyd
Performance |
| Timeline |
| Recursion Pharmaceuticals |
| Invivyd |
Recursion Pharmaceuticals and Invivyd Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Recursion Pharmaceuticals and Invivyd
The main advantage of trading using opposite Recursion Pharmaceuticals and Invivyd positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Invivyd can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invivyd will offset losses from the drop in Invivyd's long position.| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
| Invivyd vs. Recursion Pharmaceuticals | Invivyd vs. Atea Pharmaceuticals | Invivyd vs. Unity Biotechnology | Invivyd vs. Regenxbio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges |